Sustainable plastics in medical technology: between aspiration and reality

01.04.2026

The medical technology industry is currently facing fundamental change. While the highest standards of safety, functionality and hygiene continue to have top priority, there is also growing pressure to operate more sustainably and significantly reduce the ecological footprint. This area of conflict poses major challenges for companies, research institutions and political players alike - but also opens up new potential for innovation.

A current white paper from the cross-cluster project Sustainable Plastics for MedTech (SuPlaMed) addresses precisely these issues and sheds light on how plastics can be made more sustainable in medical technology. It becomes clear that plastics will continue to play a central role in the future. Due to their material properties, their versatility and their ability to meet the highest hygiene standards, it is impossible to imagine modern medicine without them. They make a decisive contribution to patient safety, particularly in the field of disposable products.
At the same time, the intensive use of plastics leads to considerable amounts of waste. A large proportion of this has so far been recycled for energy, which in turn is associated with corresponding CO₂ emissions. Against this backdrop, the development of sustainable alternatives is increasingly becoming a strategic necessity.
The white paper shows that bio-based and sustainable plastics in particular offer promising approaches. They open up the possibility of replacing fossil raw materials and reducing environmental pollution without jeopardizing the high demands of medical technology. At the same time, it is clear that sustainability cannot be viewed in isolation. In addition to ecological aspects, security of supply and resilience also play a central role. Experience in recent years has shown how vulnerable global supply chains can be. New material solutions and regional value chains can make an important contribution here.

Discover the whitepaper now

For medical technology, this development means far more than just a change in materials. It marks a structural change towards a more sustainable and at the same time more resilient industry. Companies are required to integrate sustainability into their innovation processes at an early stage - from material selection and product design through to disposal concepts.
At the same time, the transformation opens up new opportunities: those who successfully develop sustainable solutions and bring them to market can secure competitive advantages and tap into new business areas. Sustainability is becoming increasingly important as a differentiating factor, particularly in an international context.
Nevertheless, implementation is challenging. Strict regulatory requirements, high technical standards and economic issues present companies with complex decision-making processes. This makes it all the more important to pool knowledge, make best practices visible and promote innovation in a targeted manner.

The challenges outlined in the white paper make it clear that transformation is not a sure-fire success. Rather, it requires close cooperation along the entire value chain. Only when industry, research, politics and the healthcare sector act together can sustainable and marketable solutions be created.
Initiatives such as SuPlaMed show how this approach can be implemented in practice. They pool expertise, promote exchange and create the basis for innovations that are both ecologically and economically viable.

Medical technology is on a challenging yet promising path. The development of sustainable plastics is a key building block for the future of the industry.
With innovative materials, new approaches and strong cooperation, it is possible to combine ecological responsibility with the highest quality standards. The white paper provides valuable impulses for this and shows concrete perspectives for companies and organizations.